Visiogen

Irvine, United States Founded: 2001 • Age: 25 yrs Acquired By Abbott
Dual optic intraocular lenses for cataract treatment were developed.
Request Access

About Visiogen

Visiogen is a company based in Irvine (United States) founded in 2001 was acquired by Abbott in September 2009.. Visiogen has raised $40 million across 1 funding round from investors including Abbott, New Leaf Venture Partners and Novartis Venture Fund. Visiogen operates in a competitive market with competitors including RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision, among others.

  • Headquarter Irvine, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Visiogen Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $40 M (USD)

    in 1 rounds

  • Latest Funding Round
    $40 M (USD), Series C

    Apr 27, 2009

  • Investors
    Abbott

    & 7 more

  • Employee Count
    Employee Count
  • Acquired by
    Abbott

    (Sep 02, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Visiogen

Visiogen has successfully raised a total of $40M through 1 strategic funding round. The most recent funding activity was a Series C round of $40 million completed in April 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series C — $40.0M
  • First Round

    (27 Apr 2009)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2009 Amount Series C - Visiogen Valuation Novartis Venture Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Visiogen

Visiogen has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott, New Leaf Venture Partners and Novartis Venture Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made in innovative life science companies globally.
Founded Year Domain Location
Life science & tech focused VC firm investing in companies in the US
Founded Year Domain Location
Stage-agnostic investments in US life sciences are managed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Visiogen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Visiogen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Visiogen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Visiogen

Visiogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxSight, Atia Vision, STAAR Surgical, Nayam Innovations and WaveTec Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Adjustable intraocular lens technology is developed using UV-sensitive macromers.
domain founded_year HQ Location
A presbyopia-correcting intraocular lens is developed for cataract patients.
domain founded_year HQ Location
Manufacturer of implantable lenses for the eye with companion delivery systems
domain founded_year HQ Location
Artificial intraocular lenses for cataract treatment are developed.
domain founded_year HQ Location
Intraoperative guidance for IOL alignment in cataract surgery is offered.
domain founded_year HQ Location
Manufacturer of intraocular lenses and related products
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Visiogen

Frequently Asked Questions about Visiogen

When was Visiogen founded?

Visiogen was founded in 2001 and raised its 1st funding round 8 years after it was founded.

Where is Visiogen located?

Visiogen is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Is Visiogen a funded company?

Visiogen is a funded company, having raised a total of $40M across 1 funding round to date. The company's 1st funding round was a Series C of $40M, raised on Apr 27, 2009.

What does Visiogen do?

Visiogen was established in 2001 in Irvine, United States, within the ophthalmic medical device sector. The Synchrony dual optic accommodating intraocular lens was created for surgical cataract treatment addressing presbyopia. Seamless vision across near, intermediate, and distance ranges was enabled without glasses or contacts. The lens was delivered via a pre-loaded injector system. Acquisition by Abbott took place in 2009.

Who are the top competitors of Visiogen?

Visiogen's top competitors include RxSight, Nayam Innovations and Atia Vision.

Who are Visiogen's investors?
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available